Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 944.46 Mn | 654.33 Mn | 93.47 Mn | -16.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 257.80% |
| Mar 31, 2026 | -58.87% |
| Dec 31, 2025 | -18.06% |
| Sep 30, 2025 | 42.59% |
| Jun 30, 2025 | 127.54% |
| Mar 31, 2025 | -48.51% |
| Dec 31, 2024 | -6.19% |
| Sep 30, 2024 | -22.96% |
| Jun 30, 2024 | 24.18% |
| Mar 31, 2024 | -35.38% |
| Dec 31, 2023 | 70.62% |
| Sep 30, 2023 | 16.30% |
| Jun 30, 2023 | 26.27% |
| Mar 31, 2023 | 26.14% |
| Dec 31, 2022 | 54.95% |
| Sep 30, 2022 | 72.17% |
| Jun 30, 2022 | 122.40% |
| Mar 31, 2022 | 130.20% |
| Dec 31, 2021 | 40.98% |
| Sep 30, 2021 | 144.15% |